logo
Select company
Select metric
$ -47.73MEarning Before Interest & Taxes (EBIT)
VS
Market
16
Sector
37
Industry
50
History
47
$ 10.01Close
$ 9.41 - $ 18.35 52-Week Range
Ticker Information

Ticker

SPRY

Company Name

ARS PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARS PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRY - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -47.73M
3/31/2025$ -15.36M
12/31/2024$ 8.29M
9/30/2024$ -49.1M
6/30/2024$ -44.84M
3/31/2024$ -49.7M
12/31/2023$ -54.37M
9/30/2023$ -19.95M
6/30/2023$ -22.95M
3/31/2023$ -25.01M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -23.97M.
  • Over the past 5 years, ARS PHARMACEUTICALS INC's average EBIT has been $ -47.34M.
  • The median EBIT for ARS PHARMACEUTICALS INC during this period was $ -46.29M
  • ARS PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ 8.29M.
  • The lowest EBIT recorded by ARS PHARMACEUTICALS INC in the same timeframe $ -95.33M

ARS PHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
WVE : WAVE LIFE SCIENCES LTD $ -129.87MZYME : ZYMEWORKS INC $ -67.42MNAGE : NIAGEN BIOSCIENCE INC $ 18.33MCRMD : CORMEDIX INC $ 51.72MPHAT : PHATHOM PHARMACEUTICALS INC $ -257.49MURGN : UROGEN PHARMA LTD $ -136.01MGYRE : GYRE THERAPEUTICS INC $ 7MBEAM : BEAM THERAPEUTICS INC $ -398.58MANAB : ANAPTYSBIO INC $ -132.52MNRIX : NURIX THERAPEUTICS INC $ -244.02M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

SPRY - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -95.33M

Minimum

Mar 31, 2022

$ 8.29M

Maximum

Dec 31, 2024

$ -47.34M

Average

$ -46.29M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.47M with a standard deviation of $ 130.44M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.47M
median$ 847.86K
std$ 130.44M